文献速递急性肾损伤

脓毒症相关急性肾损伤的病理生理学

The Pathophysiology of Sepsis-Associated AKI.
PubMed 文献 · Clin J Am Soc Nephrol · 2022-06-28

本文综述了脓毒症相关急性肾损伤的病理生理机制,聚焦微循环功能障碍、炎症、NOD样受体蛋白3炎症小体、微小RNA、细胞外囊泡、自噬与胞葬作用、炎症反射通路、维生素D及代谢重编程等关键因素;识别这些分子靶点并定义临床亚表型将有助于实现该病的精准预防与治疗。

要点

  • 脓毒症早期支持治疗可降低死亡率,但能否预防或改善脓毒症相关急性肾损伤尚不明确。
  • 脓毒症相关急性肾损伤的具体机制尚未完全阐明,涉及微循环功能障碍、炎症及代谢重编程等多因素。
  • 识别分子靶点与临床亚表型有望推动脓毒症相关急性肾损伤的精准防治。

核心结论

  • 脓毒症相关急性肾损伤是危重症患者高发病率和高死亡率的威胁生命的并发症。
  • 明确脓毒症相关急性肾损伤的分子靶点并定义临床亚表型,将有助于实现精准预防和治疗。

研究设计与样本

  • 综述,总结近期实验室与临床研究,聚焦脓毒症相关急性肾损伤病理生理的关键因素。

主要发现

  • 脓毒症早期支持干预可降低死亡率,但预防或改善脓毒症相关急性肾损伤的证据尚不明确。
  • 脓毒症相关急性肾损伤的关键病理生理因素包括微循环功能障碍、炎症、NOD样受体蛋白3炎症小体、微小RNA、细胞外囊泡、自噬与胞葬作用、炎症反射通路、维生素D及代谢重编程。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Sepsis-associated AKI is a life-threatening complication that is associated with high morbidity and mortality in patients who are critically ill. Although it is clear early supportive interventions in sepsis reduce mortality, it is less clear that they prevent or ameliorate sepsis-associated AKI. This is likely because specific mechanisms underlying AKI attributable to sepsis are not fully understood. Understanding these mechanisms will form the foundation for the development of strategies for early diagnosis and treatment of sepsis-associated AKI. Here, we summarize recent laboratory and clinical studies, focusing on critical factors in the pathophysiology of sepsis-associated AKI: microcirculatory dysfunction, inflammation, NOD-like receptor protein 3 inflammasome, microRNAs, extracellular vesicles, autophagy and efferocytosis, inflammatory reflex pathway, vitamin D, and metabolic reprogramming. Lastly, identifying these molecular targets and defining clinical subphenotypes will permit precision approaches in the prevention and treatment of sepsis-associated AKI.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Kuwabara S, Goggins E, Okusa MD, et al. The Pathophysiology of Sepsis-Associated AKI. Clin J Am Soc Nephrol. 2022. PMID: 35764395. doi:10.2215/CJN.00850122

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。